Pyxis Oncology

About:

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

Website: https://www.pyxisoncology.com/

Top Investors: Blue Owl, RA Capital Management, Perceptive Advisors, Cormorant Asset Management, RTW Investments

Description:

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies. It was founded in 2019 and is based in Boston, Massachusetts.